CHI3L1 and pulmonary fibrosis: To evaluate the role of CHI3L1 in pulmonary vascular remodeling responses associated with pulmonary fibrosis, we treated mice with a single dose of intratracheal bleomycin (1.25 U/kg) and evaluated RV hypertrophy and vascular remodeling responses.